FDA allegedly turned down Neuralink’s proposal to start brain implant experiments on humans

According to a new Reuters investigation, despite the frequent and brazen statements of its sometimes CEO, Elon Musk, the possibilities of brain-computer interface (BCI) firm Neuralink bringing a product to market remain remote. The FDA allegedly refused the BCI business permission to perform human trials in 2022 using the same technology that killed all those pigs — basically, pig slaughter.